Who We Are

David Schaffer is Director of BBH and a faculty member in the College of Chemical and Biomolecular Engineering. With degrees in both physical and life sciences, he’s perfectly positioned to co-lead an incubator designed specifically for bioconvergence startups. As a serial entrepreneur who has co-founded 8 companies and whose technology is being used in 9 human clinical trials, with 4 to date showing efficacy, he’s experienced and enthusiastic about helping startups thrive.

Susan Jenkins is managing director of the BioEnginuity Hub, and oversees Campus Programs at BBH. With extensive experience in academic research, management of interdisciplinary research institutes, and involvement with entrepreneurship programs, she’s involved with strategic planning and administration for BBH.

Regis Kelly is director of Bakar Labs at BBH and executive director of QB3. Drawing from his experience at QB3 helping to launch two companies, a life sciences startup incubator and a venture fund, he has strategically positioned the Bakar Labs to be the world-class comprehensive incubator for life science and bioconvergence startups.

Gino Segrè is managing director of Bakar Labs at BBH, overseeing all administrative operations of the incubator and selection and integration of startup companies. As a former incubator director with QB3 and more than 15 years experience working at established life science companies, he provides strategic and funding advice to startup companies.